Xinxin Shao

1.1k total citations
46 papers, 843 citations indexed

About

Xinxin Shao is a scholar working on Molecular Biology, Surgery and Biomedical Engineering. According to data from OpenAlex, Xinxin Shao has authored 46 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Biomedical Engineering. Recurrent topics in Xinxin Shao's work include Osteoarthritis Treatment and Mechanisms (5 papers), Per- and polyfluoroalkyl substances research (4 papers) and Knee injuries and reconstruction techniques (3 papers). Xinxin Shao is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (5 papers), Per- and polyfluoroalkyl substances research (4 papers) and Knee injuries and reconstruction techniques (3 papers). Xinxin Shao collaborates with scholars based in China, Canada and Singapore. Xinxin Shao's co-authors include Christopher Hunter, Dietmar W. Hutmacher, Eng Hin Lee, James Goh, Zigang Ge, Xianjun Fu, Li Qiao, Qingcong Wei, Jianyong Zhang and Zuoqing Yuan and has published in prestigious journals such as ACS Applied Materials & Interfaces, Environmental Pollution and Chemosphere.

In The Last Decade

Xinxin Shao

37 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinxin Shao China 15 214 189 185 156 110 46 843
Yanbo Liu China 19 113 0.5× 161 0.9× 104 0.6× 91 0.6× 104 0.9× 79 1.0k
Weijian Liu China 24 195 0.9× 290 1.5× 207 1.1× 73 0.5× 175 1.6× 77 1.4k
Cecilia Romagnoli Italy 15 146 0.7× 290 1.5× 138 0.7× 64 0.4× 49 0.4× 33 876
Bin Lv China 23 264 1.2× 364 1.9× 167 0.9× 91 0.6× 38 0.3× 65 1.2k
Navneet Kumar Dubey Taiwan 20 73 0.3× 244 1.3× 278 1.5× 66 0.4× 170 1.5× 43 1.1k
Sun-Hun Kim South Korea 18 138 0.6× 327 1.7× 112 0.6× 48 0.3× 125 1.1× 40 1.1k
Shilin Li China 16 142 0.7× 198 1.0× 248 1.3× 249 1.6× 64 0.6× 78 1.1k
Lei Tong China 20 224 1.0× 336 1.8× 92 0.5× 150 1.0× 33 0.3× 63 1.1k
Yuting Sun China 18 230 1.1× 301 1.6× 85 0.5× 96 0.6× 20 0.2× 69 1.0k
Maowei Yang China 20 90 0.4× 689 3.6× 140 0.8× 84 0.5× 87 0.8× 43 1.4k

Countries citing papers authored by Xinxin Shao

Since Specialization
Citations

This map shows the geographic impact of Xinxin Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinxin Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinxin Shao more than expected).

Fields of papers citing papers by Xinxin Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinxin Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinxin Shao. The network helps show where Xinxin Shao may publish in the future.

Co-authorship network of co-authors of Xinxin Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Xinxin Shao. A scholar is included among the top collaborators of Xinxin Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinxin Shao. Xinxin Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Qian, Zhengkun Xia, Jialu Liu, et al.. (2025). Clinical practice guidelines for rituximab treatment in children with steroid-sensitive nephrotic syndrome. World Journal of Pediatrics. 21(8). 775–791.
2.
Huang, Chiao Ling, et al.. (2025). Navigating the digital learning landscape: insights into ethical dilemmas and academic misconduct among university students. International Journal of Educational Technology in Higher Education. 22(1).
4.
Shao, Xinxin, et al.. (2025). Exosome-mediated co-delivery of superoxide dismutase and chondroitinase ABC for multiple sclerosis therapy. International Journal of Biological Macromolecules. 327(Pt 1). 147438–147438. 1 indexed citations
5.
Shao, Xinxin, Yuandi Xi, Lijie Pan, et al.. (2024). The effectiveness of Tai Chi for patients with mild cognitive impairment: a systematic review and meta−analysis. Frontiers in Neuroscience. 18. 1467595–1467595. 3 indexed citations
6.
Zhao, Weijie, et al.. (2024). Deep brain stimulation for Parkinson’s disease: bibliometric analysis of the top 100 cited literature. Frontiers in Aging Neuroscience. 16. 1413074–1413074. 1 indexed citations
7.
Shao, Xinxin, Jiarui Zhang, Cong Chen, et al.. (2024). Key role of PPAR-γ-mediated suppression of the NFκB signaling pathway in rutin's antidepressant effect. Phytomedicine. 135. 156178–156178. 2 indexed citations
8.
Shao, Xinxin, et al.. (2024). Porous PLGA microspheres for the inhalation delivery of icariin and miR-23b in the treatment of metastatic lung cancer. Asian Journal of Pharmaceutical Sciences. 20(2). 101008–101008. 4 indexed citations
9.
Shao, Xinxin, et al.. (2024). The effects of different types of Tai Chi exercises on preventing falls in older adults: a systematic review and network meta-analysis. Aging Clinical and Experimental Research. 36(1). 65–65. 16 indexed citations
10.
Wang, Ziyue, et al.. (2024). PhenoAge and PhenoAgeAccel in the context of dyslipidemia: association with stroke and potential as a new predictor in the US general population. Postgraduate Medical Journal. 101(1191). 17–28. 5 indexed citations
13.
Shao, Xinxin, et al.. (2022). Superoxide dismutase-embedded metal–organic frameworks via biomimetic mineralization for the treatment of inflammatory bowel disease. Journal of Materials Chemistry B. 10(27). 5174–5181. 23 indexed citations
14.
Li, Qing, et al.. (2022). Recent trends in the development of hydrogel therapeutics for the treatment of central nervous system disorders. NPG Asia Materials. 14(1). 55 indexed citations
15.
Qiao, Li, et al.. (2022). Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma. Molecular Pharmaceutics. 19(7). 1927–1951. 24 indexed citations
16.
Qiao, Li, et al.. (2021). Research on endoplasmic reticulum–targeting fluorescent probes and endoplasmic reticulum stress–mediated nanoanticancer strategies: A review. Colloids and Surfaces B Biointerfaces. 208. 112046–112046. 25 indexed citations
17.
Ren, Xia, Xinxin Shao, Xiuxue Li, et al.. (2020). Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach. Journal of Ethnopharmacology. 258. 112932–112932. 99 indexed citations
18.
Zhou, Zhibin, Xinxin Shao, Xiaomei Yang, et al.. (2015). Influence of Hydroxyethyl Starch on Renal Function After Orthotopic Liver Transplantation. Transplantation Proceedings. 47(6). 1616–1619. 4 indexed citations
19.
Shao, Xinxin, Neil A. Duncan, Lin Lin, et al.. (2013). Serum-free media for articular chondrocytes in vitro expansion. Chinese Medical Journal. 126(13). 2523–2529. 11 indexed citations
20.
Shao, Xinxin & Christopher Hunter. (2007). Developing an alginate/chitosan hybrid fiber scaffold for annulus fibrosus cells. Journal of Biomedical Materials Research Part A. 82A(3). 701–710. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026